Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CART19 for Refractory/Relapsed B Cell Lymphoma
NCT03118180Phase 2Unknown
- Sponsor
- Zhejiang University
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in B cell lymphoma, sponsored by Zhejiang University. Primary endpoint: Overall Response Rate up to 30 months. Status: unknown.
02
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT03118180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03118180.